Description:

Benztropine mesylate 2mg tablet USP is an anticholinergic medication used as an adjunct in the symptomatic treatment of all forms of parkinsonism (idiopathic, postencephalitic, arteriosclerotic) and to control extrapyramidal symptoms (except tardive dyskinesia) induced by neuroleptic drugs (e.g., phenothiazines or reserpine). It reduces rigidity, tremor, and other motor symptoms by blocking acetylcholine in the central nervous system, helping improve muscle control and mobility.

Prescription:

• Yes

Therapeutic Category:

• Antiparkinsonian Agent / Anticholinergic

Active Ingredients/Composition:

• Benztropine mesylate USP 2 mg per tablet

Variant:

• Standard 2 mg oral tablet (round, flat-faced, beveled-edge, white/off-white, often bisected/scored for splitting; e.g., debossed markings like “IG 320”, “PMS-2”, “BEN over 2”, or similar depending on generic manufacturer). Available in 0.5 mg, 1 mg, and 2 mg strengths overall, but this is the 2 mg variant.

Consume Type:

• Oral

Directions/Usage:

• Take orally with or without food, usually 1–4 times daily (often at bedtime to minimize drowsiness). Initial adult dose for parkinsonism: 0.5–1 mg at bedtime, increase gradually (by 0.5 mg every 5–6 days) to usual 1–2 mg/day (range 0.5–6 mg/day max). For drug-induced extrapyramidal symptoms: 1–4 mg once or twice daily. Dosage must be individualized; start low and titrate slowly. Swallow whole or split if scored. Follow doctor’s exact prescription; do not stop abruptly.

Common Side Effects:

• Dry mouth, blurred vision, constipation, nausea, vomiting, nervousness/agitation, drowsiness/dizziness, urinary retention/difficulty urinating, flushing, tachycardia (fast heartbeat), confusion, or weakness. Less common: headache, fatigue, or heat intolerance (due to reduced sweating).

Package Type:

• Bottle

Storage Advice:

• Store at controlled room temperature 20–25°C (68–77°F), excursions permitted 15–30°C (59–86°F). Protect from light, moisture, and heat. Keep in original container, tightly closed. Keep out of reach of children.

Safety Advice:

• Prescription only; requires medical supervision with regular monitoring (e.g., for anticholinergic effects, mental status, or glaucoma risk). Contraindicated in children under 3 years, narrow-angle glaucoma, known hypersensitivity, or certain untreated conditions. Caution in elderly (high risk per Beers Criteria—avoid if possible due to anticholinergic burden), renal/hepatic impairment, prostatic hypertrophy, myasthenia gravis, or hot weather (risk of anhidrosis/hyperthermia). May impair mental/physical abilities (avoid driving/machinery until effects known). Risk of serious effects like paralytic ileus, heat stroke, or confusion—report fever, severe constipation, urinary issues, or hallucinations immediately. Avoid alcohol (increases sedation). Not for tardive dyskinesia. Safe in pregnancy only if benefits outweigh risks; consult doctor.

Product Substitutes:

• Cogentin 2 mg Tablets (original brand, if available)
• Generic Benztropine Mesylate 2 mg Tablets (various manufacturers like Leading Pharma, Cipla, Actavis, InvaGen, or Pendopharm/pdp-BENZTROPINE)
• Other anticholinergics like trihexyphenidyl (Artane) or procyclidine for similar indications
• In some markets: local generics or equivalents (widely available as generics in India/Africa)

Manufacturer/Marketer:

• Leading Pharma

Country of Origin:

• United States